All three cohorts were recruited through clinical trials (CAMP, PACT) or specialty clinics (GACRS), creating an enrichment for T2-high asthma (greater than 82% skin-test positive with elevated IgE; Table 1). This evidence concerns the gene IGHE and asthma.